Want to join the conversation?
$REGN 2Q15 PR: Net sales of EYLEA in the US grew 58% to $655MM from $415MM in 2Q14. Overall distributor inventory levels remained within the one- to two-week targeted range. Net sales of EYLEA outside the US were $338MM vs. $247MM in 2Q14. REGN recognized $107MM from its share of net profit from EYLEA sales outside the US compared to $67MM in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?